Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.878 |
High Similarity |
NPD7472 |
Approved |
0.872 |
High Similarity |
NPD7054 |
Approved |
0.8675 |
High Similarity |
NPD7251 |
Discontinued |
0.8667 |
High Similarity |
NPD7074 |
Phase 3 |
0.8625 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8623 |
High Similarity |
NPD7808 |
Phase 3 |
0.8614 |
High Similarity |
NPD6797 |
Phase 2 |
0.8494 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.825 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8229 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.821 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8171 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.814 |
Intermediate Similarity |
NPD8312 |
Approved |
0.814 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8129 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8095 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8054 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8024 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7879 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7838 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7838 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7831 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7831 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7818 |
Intermediate Similarity |
NPD37 |
Approved |
0.7818 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7802 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7802 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7798 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7784 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7771 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7758 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7742 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7735 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7735 |
Intermediate Similarity |
NPD6534 |
Approved |
0.773 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7722 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7706 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7684 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7654 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7611 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7607 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7594 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7594 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7594 |
Intermediate Similarity |
NPD7698 |
Approved |
0.759 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7574 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7574 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7558 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7544 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7539 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7539 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7486 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7469 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.746 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.746 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7342 |
Intermediate Similarity |
NPD943 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7329 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7329 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7287 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7219 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7215 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7164 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD9545 |
Approved |
0.715 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7680 |
Approved |
0.712 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.709 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7073 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7032 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7019 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.6994 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6988 |
Remote Similarity |
NPD2800 |
Approved |
0.6978 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6968 |
Remote Similarity |
NPD1201 |
Approved |
0.6966 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6961 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6937 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD5353 |
Approved |
0.6907 |
Remote Similarity |
NPD5005 |
Approved |
0.6907 |
Remote Similarity |
NPD5006 |
Approved |
0.6901 |
Remote Similarity |
NPD920 |
Approved |
0.6899 |
Remote Similarity |
NPD1203 |
Approved |
0.6899 |
Remote Similarity |
NPD1470 |
Approved |
0.6893 |
Remote Similarity |
NPD919 |
Approved |
0.6891 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD7999 |
Approved |
0.6886 |
Remote Similarity |
NPD1243 |
Approved |
0.6886 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD9268 |
Approved |
0.6882 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6871 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6871 |
Remote Similarity |
NPD447 |
Suspended |
0.6868 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD1091 |
Approved |
0.6855 |
Remote Similarity |
NPD2798 |
Approved |
0.6848 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6848 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6845 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6842 |
Remote Similarity |
NPD6273 |
Approved |
0.6839 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6827 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6827 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD4288 |
Approved |
0.6813
|
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |